The Roles of IL-10 and TGF-beta in Controlling IL-4 and IFN-gamma Production During Experimental Fasciola Hepatica Infection
Overview
Authors
Affiliations
Hosts infected with Fasciola hepatica experience immunosuppression during the acute and chronic phases of the disease. This immunosuppression may allow parasite survival in the face of an ongoing immune response. In bovine hosts early IL-4 and continued IgG1 production is one of the few remaining features of the characteristic type 0/2 helper (Th0/2) response present in the chronic stage of disease. Here we demonstrate elevated levels of parasite-specific, in vitro peripheral blood mononuclear cell (PBMC)-derived transforming growth factor (TGF)-beta1 from the early phases of infection and increasing levels of IL-10 as the infection becomes chronic. In vitro neutralisation of these cytokines during culture of PBMCs from experimentally-infected cattle increased IL-4 and IFN-gamma production in response to parasite-specific and non-specific stimulation. At 4 weeks p.i. neutralisation of TGF-beta results in an increase in parasite driven IL-4, while also having a greater role, compared with IL-10, in influencing specific and non-specific IFN-gamma. At 12 weeks p.i. ex vivo parasite driven IL-4 was not restored by inhibiting either IL-10 or TGF-beta. However IL-10 influenced both parasite-specific and non-specific IFN-gamma production at this time. This highlights the roles of IL-10 and TGF-beta in fasciolosis, however the cellular sources of these have yet to be defined. This suggests that suppression of IFN-gamma production by parasite molecules occurs during infection and it is possible that the suppression of IFN-gamma production may mediate parasite survival in this disease.
Ruiz-Campillo M, Pacheco I, Abril N, Bautista M, Martinez-Moreno A, Martinez-Moreno F Vet Res. 2024; 55(1):53.
PMID: 38658996 PMC: 11044403. DOI: 10.1186/s13567-024-01308-8.
The role, relevance and management of immune exhaustion in bovine infectious diseases.
Sharma S, Kumar N, Rouse B, Sharma K, Chaubey K, Singh S Heliyon. 2024; 10(7):e28663.
PMID: 38596123 PMC: 11002068. DOI: 10.1016/j.heliyon.2024.e28663.
TGF-β signaling in health, disease, and therapeutics.
Deng Z, Fan T, Xiao C, Tian H, Zheng Y, Li C Signal Transduct Target Ther. 2024; 9(1):61.
PMID: 38514615 PMC: 10958066. DOI: 10.1038/s41392-024-01764-w.
An Update on the Pathogenesis of Fascioliasis: What Do We Know?.
Tanabe M, Caravedo M, White Jr A, Cabada M Res Rep Trop Med. 2024; 15:13-24.
PMID: 38371362 PMC: 10874186. DOI: 10.2147/RRTM.S397138.
Fasciolosis: pathogenesis, host-parasite interactions, and implication in vaccine development.
Flores-Velazquez L, Ruiz-Campillo M, Herrera-Torres G, Martinez-Moreno A, Martinez-Moreno F, Zafra R Front Vet Sci. 2023; 10:1270064.
PMID: 38149297 PMC: 10750376. DOI: 10.3389/fvets.2023.1270064.